HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk factors for contrast induced nephropathy: a study among Italian patients.

Abstract
This study aimed to make a profile of patients at highest risk of developing contrast induced nephropathy (CIN) in order to take appropriate prevention measures. 591 patients undergoing coronary procedures were divided into two groups: patients with (CIN-group) and without (no-CIN) an increase in creatinine level equal or more than 25% from baseline values within 24-48 h after the coronary procedure. All patients underwent an accurate anamnesis, objective exam, hematochemical measurements, and diagnostic exams. The results of this study while confirming that, average age (p = 0.01), diabetes mellitus (p < 0.0001), base line renal insufficiency (p = 0.0001), diuretic therapy (p = 0.002), higher contrast doses (p = 0.01), are associated with a higher risk of contrast-induced nephropathy, also demonstrated that both clinical (p = 0.01) and subclinical (p < 0.0001) atherosclerosis, and higher preprocedural high sensitive C-reactive protein levels (hs- CRP) (p = 0.02) are risk factors for CIN.
AuthorsSalvatore Evola, Monica Lunetta, Francesca Macaione, Giuseppe Fonte, Gaspare Milana, Egle Corrado, Francesca Bonura, Giuseppina Novo, Enrico Hoffmann, Salvatore Novo
JournalIndian heart journal (Indian Heart J) 2012 Sep-Oct Vol. 64 Issue 5 Pg. 484-91 ISSN: 0019-4832 [Print] India
PMID23102387 (Publication Type: Journal Article)
CopyrightCopyright © 2012. Published by Elsevier B.V.
Chemical References
  • Biomarkers
  • Contrast Media
  • Creatinine
Topics
  • Aged
  • Biomarkers (blood)
  • Chi-Square Distribution
  • Contrast Media (adverse effects)
  • Coronary Angiography (adverse effects)
  • Creatinine (blood)
  • Female
  • Humans
  • Italy
  • Kidney Diseases (blood, chemically induced, diagnosis, prevention & control)
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Odds Ratio
  • Percutaneous Coronary Intervention (adverse effects)
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: